begins

Transition begins patient dosing in phase 2 study of SARM drug candidate TT701
The phase 2 study will evaluate the efficacy and safety of TT701 in improving the symptoms of androgen deficiency (sexual symptoms, fatigue/low vitality, and physical dysfunction) in men with prostate cancer who have undergone radical prostatectomy for ... [...]
4
Like
Save
Nature Cell begins U.S. phase II trials of arthritis stem cell therapy
Dubbed “Joint Stem,” Nature Cell's new therapy uses about 10 grams of fat tissue extracted from a given patient's glenoid cavity to incubate some 100 million mesenchymal stem cells, which are later compressed into a 3 cubic-centimeters injection. [...]
3
Like
Save
Amber Arkell begins her breast cancer treatment with a 'shave my head barbecue'
She was diagnosed with stage one, grade three breast cancer in December 2015 and underwent a partial mastectomy and started chemotherapy treatment. But there was one thing 26-year-old Amber Arkell was sure of: If she was going to lose her hair too, ... [...]
7
Like
Save
Progenics Pharmaceuticals begins Phase 3 study of 1404; prostate cancer …
This Phase 3 clinical trial is expected to enroll approximately 450 patients with newly diagnosed low-grade prostate cancer who are candidates for active surveillance, but nonetheless are planning to undergo radical prostatectomy. This multi-center ... [...]
7
Like
Save